Determination of lipoprotein (a) concentrations and apolipoprotein (a) molecular weights in diabetic patients.

A Ribault, MR Durou, C Letellier, F Wojcik… - Diabetes & …, 2000 - europepmc.org
Lipoprotein (a)(Lp (a)) with atherogenic and thrombotic properties has been frequently
studied in diabetes, because a high cardiovascular risk has been reported both in type 1 …

The identification of polymorphisms in the coding region of the apolipoprotein (a) gene

J Prins, FR Leus, BN Bouma… - Thrombosis and …, 1999 - thieme-connect.com
Lipoprotein (a)[Lp (a)] is a quantitative genetic trait in human plasma and elevated levels
represent a major inherited risk factor for the development of atherosclerotic disease. In our …

Lipoprotein (a) in patients with hyperlipidaemia

W Bartens, DJ Rader, G Talley - European journal of clinical …, 1995 - Wiley Online Library
Lipoprotein (a)[Lp (a)] is an atherogenic lipoprotein which is similar in structure to, but meta‐
bolically distinct from, LDL. Factors modulating plasma Lp (a) concentrations are poorly …

Structural and functional polymorphism of lipoprotein (a): biological and clinical implications

AM Scanu - Clinical chemistry, 1995 - academic.oup.com
Abstract Lipoprotein (a)[Lp (a)], a variant of low-density lipoprotein, is heterogeneous in
density because of variability in the content and composition of its core lipids and size …

Lipoprotein [a]

A Van den Ende, YY van Der Hoek… - Advances in clinical …, 1996 - Elsevier
Publisher Summary Lipoprotein a (Lp (a)) plays an important role in atherosclerosis and has
proven to be one of the most intriguing plasma lipoproteins. This chapter focuses on the …

Increased serum lipoprotein (a) concentrations and low molecular weight phenotypes of apolipoprotein (a) are associated with symptomatic peripheral arterial disease

B Dieplinger, A Lingenhel, N Baumgartner… - Clinical …, 2007 - academic.oup.com
Background: Increased concentrations of lipoprotein (a)[Lp (a)] have been considered a
genetically determined risk factor for coronary artery and cerebrovascular disease. Only 2 …

Factors affecting plasma lipoprotein (a) levels: role of hormones and other nongenetic factors

KM Kostner, GM Kostner - Seminars in Vascular Medicine, 2004 - thieme-connect.com
Lp (a) appears to be one of the most atherogenic lipoproteins. It consists of an lowdensity
lipoprotein core in addition to a covalently bound glycoprotein, apo (a). Apo (a) exists in …

Elevated plasma concentrations of lipoprotein (a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein (a).

H Dieplinger, C Lackner, F Kronenberg… - The Journal of …, 1993 - Am Soc Clin Investig
Patients with terminal renal insufficiency suffer from an increased incidence of
atherosclerotic diseases. Elevated plasma concentrations of lipoprotein (a)[Lp (a)] have …

Polymorphisms in the apolipoprotein (a) gene and their relationship to allele size and plasma lipoprotein (a) concentration

LH Puckey, RM Lawn, BL Knight - Human molecular genetics, 1997 - academic.oup.com
Genotypes at five previously described polymorphic sites at the apolipoprotein (a) gene
locus have been determined for the members of 27 families as well as for unrelated white …

The association of serum lipoprotein (a) levels, apolipoprotein (a) size and (TTTTA) n polymorphism with coronary heart disease

A Kalina, A Csaszar, G Füst, B Nagy, C Szalai… - Clinica chimica acta, 2001 - Elsevier
Background: The association between lipoprotein (a) levels, apolipoprotein (a) size and the
(TTTTA) n polymorphism which is located in the 5′ non-coding region of the apo (a) gene …